Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia

被引:0
|
作者
Jeon, Byung Ryul [1 ]
Kim, Se Hyung [2 ]
Park, Sung Kyu [2 ]
Park, Rojin [3 ]
Hong, Dae Sik [2 ]
Lee, You Kyoung [1 ]
机构
[1] Soonchunhyang Univ, Dept Lab Med & Genet, Coll Med, Bucheon, South Korea
[2] Soonchunhyang Univ, Dept Internal Med, Coll Med, Div Hematol & Oncol, Bucheon, South Korea
[3] Soonchunhyang Univ, Dept Lab Med, Coll Med, Seoul, South Korea
来源
BIOMEDICAL RESEARCH-INDIA | 2016年 / 27卷 / 04期
关键词
AML; CML; BCR/ABL1; CD; 34; enrichment; Monosomy; 7; CHRONIC MYELOID-LEUKEMIA; ACUTE MYELOBLASTIC-LEUKEMIA; IMATINIB TREATMENT; PHILADELPHIA-CHROMOSOME; INTERFERON THERAPY; ABNORMALITIES; MONOSOMY-7; HEMATOPOIESIS; EMERGENCE; CELLS;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the present study, we report a case of a 58-year-old female patient presenting with Philadelphia-chromosome (Ph)-negative blast cells and Ph-positive mature cells at diagnosis. The complete blood cell count showed the patient had a white blood cell count of 35.5 x 10(9)/L and a differential blast count of 62%. A bone marrow biopsy showed closely packed marrow with blast cell infiltration. Blasts were weakly positive for MPO stain, but negative for PAS and ANAE stains. Moreover, blasts tested positive for CD34, CD13, CD117, CD15, CD33, and CD7 and negative for TdT, CD3, CD22, and CD19 in cytometric immunophenotyping experiments. The patient, who had the karyotype 46, XX,t(9; 22) (q34; q11.2) [14]/45, XX, inv(3)(q21q26.2),-7[4], was therefore diagnosed as having AML. Fluorescence in situ hybridization (FISH) showed a decrease in Ph-positive clones and an increase in monosomy 7positive clones after CD34-positive cell enrichment, suggesting that the blasts were primarily Phnegative. This case highlights the necessity of analyzing the cytogenetic characteristics of blasts to better understand the nature of the disease when only a fraction of the cells are Ph-positive.
引用
收藏
页码:1099 / 1101
页数:3
相关论文
共 50 条
  • [41] GLOMERULONEPHRITIS AND CHRONIC MYELOGENOUS LEUKEMIA
    SPRINGATE, JE
    BRECHER, M
    BRENTJENS, J
    FELD, LG
    CHILD NEPHROLOGY AND UROLOGY, 1989, 9 (05) : 298 - 300
  • [42] Dasatinib in chronic myelogenous leukemia
    Chu, Sung-Chao
    Tang, Jih-Luh
    Li, Chi-Cheng
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10): : 1062 - 1063
  • [43] Immunotherapy in chronic myelogenous leukemia
    Guilhot, Francois
    Roy, Lydia
    Martineau, Geraldine
    Guilhot, Joelle
    Millot, Frederic
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S64 - S70
  • [44] COMPLICATIONS OF CHRONIC MYELOGENOUS LEUKEMIA
    BRUNO, MS
    OBER, WB
    NEW YORK STATE JOURNAL OF MEDICINE, 1962, 62 (09) : 1452 - &
  • [45] INTERFERON AND CHRONIC MYELOGENOUS LEUKEMIA
    LAUTA, VM
    MEDICAL ONCOLOGY, 1995, 12 (01): : 41 - 46
  • [46] CHRONIC MYELOGENOUS LEUKEMIA IN CHILDHOOD
    KANTHA, KRR
    KING, M
    LEVY, RN
    SAWITSKY, A
    ROSNER, F
    NEW YORK STATE JOURNAL OF MEDICINE, 1975, 75 (03) : 392 - 399
  • [47] SPLENECTOMY IN CHRONIC MYELOGENOUS LEUKEMIA
    DIDOLKAR, MS
    ELIAS, EG
    MITTELMAN, A
    STUTZMAN, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 106 - 106
  • [48] CHRONIC MYELOGENOUS LEUKEMIA WITH PURPURA
    EBERT, MH
    KAGEN, MS
    ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1948, 57 (03): : 458 - 458
  • [49] CYTOGENETICS OF CHRONIC MYELOGENOUS LEUKEMIA
    BERNSTEIN, R
    SEMINARS IN HEMATOLOGY, 1988, 25 (01) : 20 - 34
  • [50] Treatment of chronic myelogenous leukemia
    Kujak, Christine
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (03) : 113 - 120